Large investors often expect double-digit returns from private equity investments. Would this also be achievable for private investors? Risks and peculiarities should be very well known.
This funding round allocated in tranches will strengthen PathoQuest’s position as a leading NGS-based biosafety CRO for the biopharmaceutical industry. Paris, FRANCE, Tübingen, GERMANY – November 9th, 2021 – PathoQuest, a pioneer in the quality control of biologics using Next-Generation Sequencing (NGS), today announced the closing of a financing round up to €15M. This funding […]
Advances in technology are enabling increasingly precise and individualised treatment of diseases.
The systemic use of health data enables the transformation from hypothesis-driven medicine to data-based medicine.
Medical wearables and apps will be an essential part of telemedicine in the future. This offers new opportunities for established healthcare companies.
The use of IT and AI increases efficiency and quality of care in medicine – but also the vulnerability of the systems. How do we combine progress with security?
Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria toSweden-based Atlas Antibodies in a deal that values Evitria atmore than EUR 200m.
Artificial intelligence will revolutionise the healthcare sector in this decade. With smart concepts and innovative healthtech products, we can make the healthcare system more efficient and effective.
For the future performance and efficiency in medical care, the degree of digitalisation will be decisive, in addition to the qualified specialist staff.
Corona hits everyone, including the healthcare industry – which is essential to a functioning healthcare system.